RA CAPITAL MANAGEMENT, L.P. - 04 Mar 2024 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
ETNB
Transactions as of
04 Mar 2024
Net transactions value
+$20,722,500
Form type
4
Filing time
06 Mar 2024, 17:40:19 UTC
Previous filing
20 Feb 2024
Next filing
25 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Purchase $20,722,500 +1,350,000 +12% $15.35 12,431,584 04 Mar 2024 See Footnotes F1, F2, F3
holding ETNB Common Stock 335,364 04 Mar 2024 See Footnotes F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired from the Issuer in an at-the-market offering.
F2 Held directly by the RA Capital Healthcare Fund, L.P. (the "Fund").
F3 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F4 Held directly by the Nexus Fund.

Remarks:

Dr. Derek DiRocco, a Partner of the Adviser, serves on the Issuer's board of directors.